Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Price:
5.4 USD
1.89%
Market Closed
Updated:
Jun 11, 2024
Aurinia Pharmaceuticals Inc
Common Shares Outstanding
|
Aurinia Pharmaceuticals Inc
Common Shares Outstanding Peer Comparison
Comparables:
ZYME
TH
RPTX
FUSN
EDT
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Common Shares Outstanding
$143.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
16%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Common Shares Outstanding
$70.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Common Shares Outstanding
$46m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-3%
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Common Shares Outstanding
$42.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Common Shares Outstanding
$79.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Common Shares Outstanding
CA$279.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
See Also
What is Aurinia Pharmaceuticals Inc's Common Shares Outstanding?
Common Shares Outstanding
143.7m
USD
143.7m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Common Shares Outstanding amounts to 143.7m USD.
What is Aurinia Pharmaceuticals Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
16%
16%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Aurinia Pharmaceuticals Inc have been 4% over the past three years , 9% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
